{"id":21515,"date":"2021-06-25T16:08:00","date_gmt":"2021-06-25T16:08:00","guid":{"rendered":"https:\/\/celonpharma.com\/?p=21515"},"modified":"2021-06-28T16:26:19","modified_gmt":"2021-06-28T16:26:19","slug":"current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/","title":{"rendered":"Current report 28\/2021 \u2013 Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A."},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Date: 06\/24\/2021- 7:28 pm<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Management Board of Celon Pharma S.A. (the &#8220;Company&#8221;) informs that the Company and Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A. with its registered seat in Warsaw (&#8220;TZF&#8221;) signed a letter of intent on June 24, 2021. The parties have declared that:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8211; taking into account that the Company has both the competences and the technical capacity to develop innovative pharmaceuticals with potential use in the treatment and prevention of COVID-19, treatment of cancer, neurological diseases, diabetes and other metabolic diseases<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">and<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8211; taking into account that TZF has commenced implementation of an investment in the form of creating a research and production center for highly-active substances (high-potency active pharmaceutical ingredients, HP-APIs),<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">in order to take full advantage of the synergy of the teams\u2019 experience and technological advancement of both companies, the Company and TZF declare their intention to start cooperation in the area of development (R&amp;D) and production (fill &amp; finish) of medicinal products based on modern technologies (m-RNA), a platform of HP-API drugs with particular focus on new technologies supporting sterile drug forms in to be used in infectious diseases, oncology and metabolic diseases.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The detailed scope of cooperation is to be specified in the potential cooperation agreement.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A.<\/p>\n","protected":false},"author":20,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[46],"tags":[],"class_list":["post-21515","post","type-post","status-publish","format-standard","hentry","category-current-reports"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Current report 28\/2021 \u2013 Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A. - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Current report 28\/2021 \u2013 Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A. - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-25T16:08:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-28T16:26:19+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\\\/\"},\"author\":{\"name\":\"Ma\u0142gorzata Siewierska\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\"},\"headline\":\"Current report 28\\\/2021 \u2013 Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A.\",\"datePublished\":\"2021-06-25T16:08:00+00:00\",\"dateModified\":\"2021-06-28T16:26:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\\\/\"},\"wordCount\":222,\"articleSection\":[\"Current reports\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\\\/\",\"name\":\"Current report 28\\\/2021 \u2013 Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A. - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"datePublished\":\"2021-06-25T16:08:00+00:00\",\"dateModified\":\"2021-06-28T16:26:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Current report 28\\\/2021 \u2013 Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\",\"name\":\"Ma\u0142gorzata Siewierska\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Current report 28\/2021 \u2013 Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A. - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/","og_locale":"en_US","og_type":"article","og_title":"Current report 28\/2021 \u2013 Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A. - Celon Pharma","og_description":"Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A.","og_url":"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/","og_site_name":"Celon Pharma","article_published_time":"2021-06-25T16:08:00+00:00","article_modified_time":"2021-06-28T16:26:19+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/"},"author":{"name":"Ma\u0142gorzata Siewierska","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c"},"headline":"Current report 28\/2021 \u2013 Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A.","datePublished":"2021-06-25T16:08:00+00:00","dateModified":"2021-06-28T16:26:19+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/"},"wordCount":222,"articleSection":["Current reports"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/","url":"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/","name":"Current report 28\/2021 \u2013 Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A. - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"datePublished":"2021-06-25T16:08:00+00:00","dateModified":"2021-06-28T16:26:19+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/current-report-28-2021-signing-of-a-letter-of-intent-on-commencing-cooperation-with-tarchominskie-zaklady-farmaceutyczne-s-a\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Current report 28\/2021 \u2013 Signing of a letter of intent on commencing cooperation with Tarchomi\u0144skie Zak\u0142ady Farmaceutyczne S.A."}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c","name":"Ma\u0142gorzata Siewierska"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/21515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=21515"}],"version-history":[{"count":2,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/21515\/revisions"}],"predecessor-version":[{"id":21520,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/21515\/revisions\/21520"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=21515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=21515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=21515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}